Clinical manifestation and management of immune checkpoint inhibitor‐associated cardiotoxicity

Immune checkpoint inhibitors (ICIs) targeting programmed death‐1 (PD‐1), its ligand (PD‐L1), and cytotoxic T‐lymphocyte‐associated antigen 4 (CTLA4) have revolutionized cancer treatment by recovering the attack of T lymphocytes on the malignant cells. They have improved clinical outcomes dramaticall...

Full description

Saved in:
Bibliographic Details
Published in:Thorac Cancer
Main Authors: Guo, Xiaoxiao, Wang, Hanping, Zhou, Jiaxin, Li, Yue, Duan, Lian, Si, Xiaoyan, Zhang, Li, Fang, Ligang
Format: Artigo
Language:Inglês
Published: John Wiley & Sons Australia, Ltd 2019
Subjects:
Clinical Guideline
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6996973/
https://ncbi.nlm.nih.gov/pubmed/31849171
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.13250
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items